Vimarsana
Biggest News Aggregation in the World

Page 3 - Additional Policy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Additional Policy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Additional Policy Today - Breaking & Trending Today

Employee Benefits & Executive Compensation 2020 Year-End Client Advisory | Verrill - Vimarsana News

Employee Benefits & Executive Compensation 2020 Year-End Client Advisory | Verrill

A Chronology of COVID-19 Relief for ERISA Plans In 2020, the employee benefits world was dominated by the COVID-19 pandemic. The following chronology highlights the ongoing relief provided by legislation, regulatory action, and other agency guidance to assist ERISA plan participants, fiduciaries, and sponsors during the ongoing COVID-19 pandemic through November 30, 2020. (Superseded agency guidance has been omitted.) We provide a number of links to articles on our blog, Benefits Law Update, which offer additional information about many of these important regulatory changes. Much of the guida...

Executive Summary: Tracking Telehealth Changes State-by-State in Response to COVID-19 - December 2020 | Manatt, Phelps & Phillips, LLP - Vimarsana News

Executive Summary: Tracking Telehealth Changes State-by-State in Response to COVID-19 - December 2020 | Manatt, Phelps & Phillips, LLP

[co-authors: Adrienne Peng, and Michelle Fong] As the COVID-19 pandemic continues across the United States, states, payers, and providers are looking for ways to expand access to telehealth services. Telehealth is an essential tool in ensuring patients are able to access the healthcare services they need in as safe a manner as possible. In order to provide our clients with quick and actionable guidance on the evolving telehealth landscape, Manatt Health has developed a federal and comprehensive 50-state tracker for policy, regulatory and legal changes related to telehealth during the COVID-19...